Biocon Biologics receives MHRA UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The audit has been concluded with no major observations
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Granules India receives 1 observation from USFDA for Chantilly facility
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated